By Admin | 21/09/2017 | 5 Comments
1. Characterisation of the food/constituent The food constituent that is the subject of the health claim is “Lacprodan CGMP-10 (active ingredient: sialic acid)”. Sialic acid can be measured by established methods. The Panel considers that the food constituent, sialic acid, which is the subject of the health claim, is sufficiently characterised. 2. Relevance of the claimed effect to human health the claimed effect is “plays a role in development of the brain”. The Panel assumes that the target population is the general population. “Plays a role in development of the brain” is not sufficiently defined. In the context of the proposed wording, the Panel notes that the claimed effect relates to learning and memory. Learning and memory are well-defined constructs which can be measured by established methods. The Panel considers that normal learning and memory are beneficial to human health.
On the basis of the data available, the Panel concludes that: The food constituent, sialic acid, which is the subject of the health claim is sufficiently characterised. The claimed effect is “plays a role in development of the brain”. The target population is assumed to be the general population. In the context of the proposed wording, the claimed effect relates to learning and memory. Normal learning and memory are beneficial to human health. A cause and effect relationship has not been established between the dietary intake of sialic acid and normal learning and memory.